Non-Small Cell Lung Cancer (NSCLC) Latest Advances

Find the Latest Research About Non-Small Cell Lung Cancer (NSCLC)

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102386 publications

PDLIM2 in Lung Adenocarcinoma Metastasis.

PDLIM2 in Lung Adenocarcinoma Metastasis.

Journal: bioRxiv : the preprint server for biology
Published: January 23, 2026

Safety analysis of vinorelbine in the real world: a pharmacovigilance study based on the FAERS database.

Safety analysis of vinorelbine in the real world: a pharmacovigilance study based on the FAERS database.

Journal: Journal of chemotherapy (Florence, Italy)
Published: January 23, 2026

Overcoming EGFR resistance by monovalent and bident inhibitors targeting Cys775.

Overcoming EGFR resistance by monovalent and bident inhibitors targeting Cys775.

Journal: bioRxiv : the preprint server for biology
Published: January 23, 2026

Tumor-Targeted Delivery of an EGFR Inhibitor Prodrug via Site-Specific Albumin Conjugation.

Tumor-Targeted Delivery of an EGFR Inhibitor Prodrug via Site-Specific Albumin Conjugation.

Journal: Journal of medicinal chemistry
Published: January 23, 2026

Cost-Effectiveness of Adjuvant Immunotherapy in Cancer Treatments: A Systematic Review.

Cost-Effectiveness of Adjuvant Immunotherapy in Cancer Treatments: A Systematic Review.

Journal: JAMA oncology
Published: January 22, 2026

BR.31 Trial: Adjuvant Durvalumab as the Third Contender in Resected Non-Small Cell Lung Cancer.

BR.31 Trial: Adjuvant Durvalumab as the Third Contender in Resected Non-Small Cell Lung Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 22, 2026

Predictors of distant, local and lymph node recurrence for surgically treated non-small cell lung cancer (NSCLC) patients: Retrospective analysis of pathological T1-4, N0, R0, M0 tumor stages.

Predictors of distant, local and lymph node recurrence for surgically treated non-small cell lung cancer (NSCLC) patients: Retrospective analysis of pathological T1-4, N0, R0, M0 tumor stages.

Journal: Pneumologie (Stuttgart, Germany)
Published: January 22, 2026

Prevalence and Clinical Characteristics of Germline Epidermal Growth Factor Receptor Mutations in the Southeastern Unites States.

Prevalence and Clinical Characteristics of Germline Epidermal Growth Factor Receptor Mutations in the Southeastern Unites States.

Journal: JCO precision oncology
Published: January 21, 2026

The evolving role of radiotherapy in advanced non-small cell lung cancer: beyond symptom control.

The evolving role of radiotherapy in advanced non-small cell lung cancer: beyond symptom control.

Journal: Annals of palliative medicine
Published: January 21, 2026

Deep radiomics for prognostic prediction in locally advanced non-small cell lung cancer by leveraging OmicsMap-based image representation.

Deep radiomics for prognostic prediction in locally advanced non-small cell lung cancer by leveraging OmicsMap-based image representation.

Journal: Physics in medicine and biology
Published: January 21, 2026

Impact of Real-World Response to First-Line Immunotherapy and Chemotherapy on Subsequent Treatment Outcomes in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer.

Impact of Real-World Response to First-Line Immunotherapy and Chemotherapy on Subsequent Treatment Outcomes in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer.

Journal: JCO clinical cancer informatics
Published: January 21, 2026

Real-World Patients Management and Referral Patterns in Patients With Stage III Unresectable Non-Small Cell Lung Cancer in Poland.

Real-World Patients Management and Referral Patterns in Patients With Stage III Unresectable Non-Small Cell Lung Cancer in Poland.

Journal: JCO global oncology
Published: January 21, 2026
Showing 1-12 of 102,386

Last Updated: 02/24/2026